Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2
Saved in:
| Published in: | Blood and Lymphatic Cancer : Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552785474093056 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Blood and Lymphatic Cancer : Targets and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61055 |
| institution | FRELIP |
| journal_source_facet | Blood and Lymphatic Cancer : Targets and Therapy |
| last_indexed | 2026-06-20T21:26:07.255Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 |
| title_alt | Disparidades en salud en pacientes con leucemia mieloide aguda sometidos a tratamiento con inhibidores de tirosina quinasa dirigidos a FLT3, IDH1 o IDH2 Disparités en santé chez les patients atteints de leucémie aiguë myéloïde traités par inhibiteur de tyrosine kinase (ITK) ciblant FLT3, IDH1 ou IDH2 Disparidades de saúde em pacientes com leucemia mieloide aguda submetidos a tratamento com inibidor de tirosina quinase (TKI) direcionado a FLT3, IDH1 ou IDH2 |
| title_auth | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 |
| title_es_txt | Disparidades en salud en pacientes con leucemia mieloide aguda sometidos a tratamiento con inhibidores de tirosina quinasa dirigidos a FLT3, IDH1 o IDH2 |
| title_fr_txt | Disparités en santé chez les patients atteints de leucémie aiguë myéloïde traités par inhibiteur de tyrosine kinase (ITK) ciblant FLT3, IDH1 ou IDH2 |
| title_full | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 |
| title_fullStr | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 |
| title_full_unstemmed | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 |
| title_pt_txt | Disparidades de saúde em pacientes com leucemia mieloide aguda submetidos a tratamento com inibidor de tirosina quinase (TKI) direcionado a FLT3, IDH1 ou IDH2 |
| title_short | Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2 |
| title_sort | health disparities in acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (tki) therapy targeting flt3, idh1, or idh2 |
| topic | Oncology General Oncology |
| url | https://www.dovepress.com/health-disparities-in-acute-myeloid-leukemia-patients-undergoing-treat-peer-reviewed-fulltext-article-BLCTT |